Identification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassay

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Tebbets, Brad ^a,b   Stewart, Douglas ^a   Lawry, Stephanie ^a,b   Nett, Jeniel ^a   Nantel, Andre ^c   Andes, David ^a   Klein, Bruce S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTISONE; FLUCONAZOLE; FLUDIOXONIL; UNCLASSIFIED DRUG; PROTEIN HISTIDINE KINASE; PROTEIN KINASE; PROTEIN-HISTIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BIOASSAY; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCUS; DISK DIFFUSION; DOWN REGULATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; FUNGAL STRAIN; FUNGUS GROWTH; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; MAGNAPORTHE GRISEA; MALE; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RHIZOPUS ORYZAE; SACCHAROMYCES CEREVISIAE; SINGLE DRUG DOSE; UPREGULATION; ANTIFUNGAL RESISTANCE; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; REPORTER GENE;

ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; MAGNAPORTHE GRISEA; MAMMALIA; RHIZOPUS ORYZAE; SACCHAROMYCES CEREVISIAE;

ANTIFUNGAL AGENTS; BIOFILMS; BIOLOGICAL ASSAY; CANDIDA ALBICANS; DNA DAMAGE; DNA REPAIR; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FLUCONAZOLE; GENES, REPORTER; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASES; SACCHAROMYCES CEREVISIAE;

EID: 84860511581     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036021     Document Type: Article

References (38)

1. Richardson MD, (2005) Changing patterns and trends in systemic fungal infections. The Journal of antimicrobial chemotherapy 56 (Suppl 1): i5-i11.
2. Gupte M, Kulkarni P, Ganguli BN, (2002) Antifungal antibiotics. Appl Microbiol Biotechnol 58: 46-57.
3. Li D, Agrellos OA, Calderone R, (2010) Histidine kinases keep fungi safe and vigorous. Current opinion in microbiology 13: 424-430.
4. Catlett NL, Yoder OC, Turgeon BG, (2003) Whole-genome analysis of two-component signal transduction genes in fungal pathogens. Eukaryot Cell 2: 1151-1161.
5. Clemons KV, Miller TK, Selitrennikoff CP, Stevens DA, (2002) fos-1, a putative histidine kinase as a virulence factor for systemic aspergillosis. Medical mycology: official publication of the International Society for Human and Animal Mycology 40: 259-262.
6. Yamada-Okabe T, Mio T, Ono N, Kashima Y, Matsui M, et al. (1999) Roles of three histidine kinase genes in hyphal development and virulence of the pathogenic fungus Candida albicans. J Bacteriol 181: 7243-7247.
7. Nemecek JC, Wuthrich M, Klein BS, (2006) Global control of dimorphism and virulence in fungi. Science 312: 583-588.
8. Ochiai N, Fujimura M, Oshima M, Motoyama T, Ichiishi A, et al. (2002) Effects of iprodione and fludioxonil on glycerol synthesis and hyphal development in Candida albicans. Biosci Biotechnol Biochem 66: 2209-2215.
9. Pott GB, Miller TK, Bartlett JA, Palas JS, Selitrennikoff CP, (2000) The isolation of FOS-1, a gene encoding a putative two-component histidine kinase from Aspergillus fumigatus. Fungal Genet Biol 31: 55-67.
10. Motoyama T, Kadokura K, Ohira T, Ichiishi A, Fujimura M, et al. (2005) A two-component histidine kinase of the rice blast fungus is involved in osmotic stress response and fungicide action. Fungal Genet Biol 42: 200-212.
11. Motoyama T, Ohira T, Kadokura K, Ichiishi A, Fujimura M, et al. (2005) An Os-1 family histidine kinase from a filamentous fungus confers fungicide-sensitivity to yeast. Curr Genet 47: 298-306.
12. Green S, Moehle C, (2001) Media and Culture of Yeast. In: Bonifacino JSDM, Harford JB, Lippincott Schwartz J, Yamada KM, editors. Current Protocols in Cell Biology New York John Wiley and Sons, Inc pp. 1.6.1-1.6.12.
13. Nantel A, Rigby T, Hogues H, Whiteway M, (2007) Microarrays for Studying Pathogenicity in Candida albicans. In: Kavanagh K, editors. Medical Mycology: Cellular and Molecular Techniques Chichester, UK John Wiley & Sons, Ltd pp. 181-210.
14. Hussein B, Huang H, Glory A, Osmani A, Kaminskyj S, et al. (2011) G1/S transcription factor orthologues Swi4p and Swi6p are important but not essential for cell proliferation and influence hyphal development in the fungal pathogen Candida albicans. Eukaryotic cell 10: 384-397.
15. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T, (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432.
16. Schmitt MA, Weisblum B, Gellman SH, (2007) Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Journal of the American Chemical Society 129: 417-428.
17. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, et al. (2007) Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrobial agents and chemotherapy 51: 510-520.
18. Hawser SP, Norris H, Jessup CJ, Ghannoum MA, (1998) Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. Journal of clinical microbiology 36: 1450-1452.
19. Uppuluri P, Nett J, Heitman J, Andes D, (2008) Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrobial agents and chemotherapy 52: 1127-1132.
20. Nett JE, Marchillo K, Spiegel CA, Andes DR, (2010) Development and validation of an in vivo Candida albicans biofilm denture model. Infection and immunity 78: 3650-3659.
21. White TC, Marr KA, Bowden RA, (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clinical microbiology reviews 11: 382-402.
22. Ochiai N, Fujimura M, Motoyama T, Ichiishi A, Usami R, et al. (2001) Characterization of mutations in the two-component histidine kinase gene that confer fludioxonil resistance and osmotic sensitivity in the os-1 mutants of Neurospora crassa. Pest Manag Sci 57: 437-442.
23. Yoshimi A, Tsuda M, Tanaka C, (2004) Cloning and characterization of the histidine kinase gene Dic1 from Cochliobolus heterostrophus that confers dicarboximide resistance and osmotic adaptation. Molecular genetics and genomics: MGG 271: 228-236.
24. Kanetis L, Forster H, Jones CA, Borkovich KA, Adaskaveg JE, (2008) Characterization of genetic and biochemical mechanisms of fludioxonil and pyrimethanil resistance in field isolates of Penicillium digitatum. Phytopathology 98: 205-214.
25. Avenot H, Simoneau P, Iacomi-Vasilescu B, Bataille-Simoneau N, (2005) Characterization of mutations in the two-component histidine kinase gene AbNIK1 from Alternaria brassicicola that confer high dicarboximide and phenylpyrrole resistance. Current genetics 47: 234-243.
26. Enjalbert B, Smith DA, Cornell MJ, Alam I, Nicholls S, et al. (2006) Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. Molecular Biology of the Cell 17: 1018-1032.
27. Puertollano R, Bonifacino JS, (2004) Interactions of GGA3 with the ubiquitin sorting machinery. Nature cell biology 6: 244-251.
28. Masson JY, Ramotar D, (1996) The Saccharomyces cerevisiae IMP2 gene encodes a transcriptional activator that mediates protection against DNA damage caused by bleomycin and other oxidants. Molecular and cellular biology 16: 2091-2100.
29. Vylkova S, Jang WS, Li W, Nayyar N, Edgerton M, (2007) Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway. Eukaryot Cell 6: 1876-1888.
30. Douglas LJ, (2003) Candida biofilms and their role in infection. Trends in microbiology 11: 30-36.
31. Hagiwara D, Asano Y, Marui J, Furukawa K, Kanamaru K, et al. (2007) The SskA and SrrA response regulators are implicated in oxidative stress responses of hyphae and asexual spores in the phosphorelay signaling network of Aspergillus nidulans. Biosci Biotechnol Biochem 71: 1003-1014.
32. Mukherjee U, Basak J, Chatterjee SN, (1990) DNA damage and cell killing by nitrofurantoin in relation to its carcinogenic potential. Cancer biochemistry biophysics 11: 275-287.
33. McCalla DR, Reuvers A, Kaiser C, (1971) Breakage of bacterial DNA by nitrofuran derivatives. Cancer research 31: 2184-2188.
34. Lamb D, Kelly D, Kelly S, (1999) Molecular aspects of azole antifungal action and resistance. Drug Resist Updat 2: 390-402.
35. Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, et al. (2002) Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 46: 3113-3117.
36. Arana DM, Nombela C, Pla J, (2010) Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes. J Antimicrob Chemother 65: 54-62.
37. Florio AR, Ferrari S, De Carolis E, Torelli R, Fadda G, et al. (2011) Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A. BMC microbiology 11: 97.
38. Sharma M, Manoharlal R, Negi AS, Prasad R, (2010) Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res 10: 570-578.